Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis

Publikation: Bidrag til tidsskriftLetterfagfællebedømt

Standard

Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis. / Nielsen, Valdemar Wendelboe; Lund, Tamara Theresia; Gniadecki, Robert; Olsen, Rasmus Huan; Nissen, Christoffer Valdemar; Schwensen, Jakob Ferløv Baselius; Thomsen, Simon Francis.

I: Dermatologic Therapy, Bind 33, Nr. 6, e14258, 2020.

Publikation: Bidrag til tidsskriftLetterfagfællebedømt

Harvard

Nielsen, VW, Lund, TT, Gniadecki, R, Olsen, RH, Nissen, CV, Schwensen, JFB & Thomsen, SF 2020, 'Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis', Dermatologic Therapy, bind 33, nr. 6, e14258. https://doi.org/10.1111/dth.14258

APA

Nielsen, V. W., Lund, T. T., Gniadecki, R., Olsen, R. H., Nissen, C. V., Schwensen, J. F. B., & Thomsen, S. F. (2020). Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis. Dermatologic Therapy, 33(6), [e14258]. https://doi.org/10.1111/dth.14258

Vancouver

Nielsen VW, Lund TT, Gniadecki R, Olsen RH, Nissen CV, Schwensen JFB o.a. Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis. Dermatologic Therapy. 2020;33(6). e14258. https://doi.org/10.1111/dth.14258

Author

Nielsen, Valdemar Wendelboe ; Lund, Tamara Theresia ; Gniadecki, Robert ; Olsen, Rasmus Huan ; Nissen, Christoffer Valdemar ; Schwensen, Jakob Ferløv Baselius ; Thomsen, Simon Francis. / Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis. I: Dermatologic Therapy. 2020 ; Bind 33, Nr. 6.

Bibtex

@article{ffaf2ca328224eabb0d2153693a367e5,
title = "Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis",
author = "Nielsen, {Valdemar Wendelboe} and Lund, {Tamara Theresia} and Robert Gniadecki and Olsen, {Rasmus Huan} and Nissen, {Christoffer Valdemar} and Schwensen, {Jakob Ferl{\o}v Baselius} and Thomsen, {Simon Francis}",
year = "2020",
doi = "10.1111/dth.14258",
language = "English",
volume = "33",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis

AU - Nielsen, Valdemar Wendelboe

AU - Lund, Tamara Theresia

AU - Gniadecki, Robert

AU - Olsen, Rasmus Huan

AU - Nissen, Christoffer Valdemar

AU - Schwensen, Jakob Ferløv Baselius

AU - Thomsen, Simon Francis

PY - 2020

Y1 - 2020

U2 - 10.1111/dth.14258

DO - 10.1111/dth.14258

M3 - Letter

C2 - 32865289

VL - 33

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 6

M1 - e14258

ER -

ID: 252044073